
Sign up to save your podcasts
Or


In this episode we interview Dr. Rona Hu on how to manage aggression and agitation in patients. Agitation and aggression in patients is a serious and potentially dangerous consequence of psychiatric illness. In this episode, we explore the most current, effective non-pharmacological and pharmacological treatments available for the management of aggression and agitation.
Dr. Hu is Medical Director of the Acute Psychiatric Inpatient Unit at Stanford Hospital, specializing in the care of those with serious mental illnesses, including schizophrenia, bipolar and depression. She completed medical school and residency in psychiatry at the University of California, San Francisco, and fellowships in Pharmacology and Schizophrenia Research through the National Institutes of Health. She is also active in the minority issues and cultural psychiatry, and has received regional and national recognition for her clinical care, research and teaching.
Disclaimer: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses.
Send feedback on Facebook or LinkedIn. Rate us on iTunes!
By Neuroscience Education Institute4.5
128128 ratings
In this episode we interview Dr. Rona Hu on how to manage aggression and agitation in patients. Agitation and aggression in patients is a serious and potentially dangerous consequence of psychiatric illness. In this episode, we explore the most current, effective non-pharmacological and pharmacological treatments available for the management of aggression and agitation.
Dr. Hu is Medical Director of the Acute Psychiatric Inpatient Unit at Stanford Hospital, specializing in the care of those with serious mental illnesses, including schizophrenia, bipolar and depression. She completed medical school and residency in psychiatry at the University of California, San Francisco, and fellowships in Pharmacology and Schizophrenia Research through the National Institutes of Health. She is also active in the minority issues and cultural psychiatry, and has received regional and national recognition for her clinical care, research and teaching.
Disclaimer: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses.
Send feedback on Facebook or LinkedIn. Rate us on iTunes!

1,327 Listeners

2,504 Listeners

3,349 Listeners

154 Listeners

1,351 Listeners

729 Listeners

291 Listeners

359 Listeners

569 Listeners

470 Listeners

734 Listeners

373 Listeners

19,697 Listeners

189 Listeners

150 Listeners